COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention recommends people aged 65 and older and those who are immunocompromised receive a second dose of the 2024-2025 COVID-19 vaccine six months after the first dose.
The Centers for Medicare & Medicaid Services released final guidance detailing reporting requirements for the hospital respiratory data condition of participation.
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their patients’ safe during respiratory virus season.
The Centers for Disease Control and Prevention and the Tri-Council for Nursing will host a webinar to help nurses and other health professionals prepare for the 2024-2025 fall/winter respiratory virus season on Sept. 16 from 2:00-3:00 p.m. ET.
The Centers for Disease Control and Prevention’s COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest rate since January 2022.
The Centers for Disease Control and Prevention recommended the updated 2024-2025 COVID-19 and flu vaccines for this fall and winter.
The Centers for Disease Control and Prevention recently urged nursing home residents to become vaccinated, following the release of research showing only 33% of residents were up to date with their COVID-19 vaccination.
The Food and Drug Administration this week authorized using a single dose of the Moderna or Pfizer bivalent COVID-19 vaccine for primary vaccination as well as for future doses.
The Centers for Disease Control and Prevention has added COVID-19 vaccines to the U.S. 2023 immunization schedules for adults and children.
The Department of Health and Human Services will launch a national advertising campaign and tour to encourage families to get the updated Pfizer or Moderna COVID-19 vaccine booster.